Jazz Pharmaceuticals JAZZ announced that a mid-stage study evaluating the efficacy and safety of its investigational candidate, suvecaltamide (JZP385), in adult patients with essential tremor (ET) did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results